Molecular Biology of the Cell track citations

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
QUICK SEARCH:   [advanced]


     

MBC in Press, published online ahead of print February 15, 2006
Mol. Biol. Cell 10.1091/mbc.E05-08-0749

A more recent version of this article appeared on May 1, 2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
E05-08-0749v1
17/5/2223    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dunham-Ems, S. M.
Right arrow Articles by Stachowiak, M. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dunham-Ems, S. M.
Right arrow Articles by Stachowiak, M. K.

Submitted on August 11, 2005
Revised on February 3, 2006
Accepted on February 8, 2006

Factors Controlling Fibroblast Growth Factor Receptor-1’s Cytoplasmic Trafficking and Its Regulation as Revealed by FRAP Analysis

Star M. Dunham-Ems,*{dagger} Haridas E. Pudavar,{dagger} Jason M. Myers,* Pamela A. Maher,{ddagger} Paras N. Prasad,{dagger} and Michal K. Stachowiak*{dagger}

*Molecular and Structural Neurobiology and Gene Therapy Program, Department of Pathology and Anatomical Sciences, State University of New York at Buffalo, Buffalo, NY 14214; {dagger}Institute for Lasers, Photonics, and BioPhotonics, Department of Chemistry, State University of New York at Buffalo, Buffalo NY 14260; {ddagger}The Salk Institute, La Jolla, CA 92037

Monitoring Editor: Suzanne Pfeffer

Biochemical and microscopic studies have indicated that FGFR1 is a transmembrane and soluble protein present in the cytosol and nucleus. How FGFR1 enters the cytosol and subsequently the nucleus to control cell development and associated gene activities has become a compelling question. Analyses of protein synthesis, cytoplasmic subcompartmental distribution and movement of FGFR1-EGFP and FGFR1 mutants showed that FGFR1 exists as three separate populations (a) a newly synthesized, highly mobile, nonglycosylated, cytosolic receptor that is depleted by Brefeldin A and resides outside the ER-golgi lumen, (b) a slowly diffusing membrane receptor population and (c) an immobile membrane pool increased by Brefeldin A. RSK1 increases the highly mobile cytosolic FGFR1 population and its overall diffusion rate leading to increased FGFR1 nuclear accumulation, which coaccumulates with RSK1. A model is proposed in which newly synthesized FGFR1 can enter the (a) ‘nuclear pathway’, where the nonglycosylated receptor is extruded from the pre-Golgi producing highly mobile cytosolic receptor molecules that rapidly accumulate in the nucleus or (b) ‘membrane pathway’ in which FGFR1 is processed through the Golgi, where its movement is spatially restricted to trans-Golgi membranes with limited lateral mobility. Entrance into the nuclear pathway is favored by FGFR1’s interaction with kinase active RSK1.

Address correspondence to: Michal K. Stachowiak (mks{at}buffalo.edu)




This article has been cited by other articles:


Home page
 J. Immunol.Home page
Y.-P. Jin, Y. Korin, X. Zhang, P. T. Jindra, E. Rozengurt, and E. F. Reed
RNA Interference Elucidates the Role of Focal Adhesion Kinase in HLA Class I-Mediated Focal Adhesion Complex Formation and Proliferation in Human Endothelial Cells
J. Immunol., June 15, 2007; 178(12): 7911 - 7922.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Copyright © 2006 by The American Society for Cell Biology. Terms of copyright protection, warranties, and disclaimers.